| # | Drug | Count |
|---|---|---|
| 0 | OCTREOTIDE ACETATE | 39 |
| 1 | ETOPOSIDE | 21 |
| 2 | CARBOPLATIN | 20 |
| 3 | ASPIRIN | 19 |
| 4 | ASPIRIN 325 MG | 19 |
| 5 | ASPIRIN 81 MG | 19 |
| 6 | ADALIMUMAB | 18 |
| 7 | PREDNISONE | 15 |
| 8 | DEXAMETHASONE | 14 |
| 9 | DEXAMETHASONE 1.5 MG | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DRS LIDOCAINE 5% CREAM | 1 | 0.0222 |
| 1 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 2 | TRIPTORELIN PAMOATE | 4 | 0.0015 |
| 3 | LUTETIUM LU 177 DOTATATE | 8 | 0.0014 |
| 4 | DIAZOXIDE | 1 | 0.0014 |
| 5 | OCTREOTIDE ACETATE | 39 | 0.0013 |
| 6 | TAZEMETOSTAT | 2 | 0.0012 |
| 7 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 8 | TELOTRISTAT ETHYL | 6 | 0.0010 |
| 9 | LANREOTIDE ACETATE | 7 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 36 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Platinum-based Drug [EPC] | 27 |
| 3 | Topoisomerase Inhibitor [EPC] | 21 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 19 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 6 | Kinase Inhibitor [EPC] | 14 |
| 7 | Proton Pump Inhibitor [EPC] | 14 |
| 8 | Calcium Channel Blocker [EPC] | 13 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Somatostatin Analog [EPC] | 10 | 0.0015 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 3 | 0.0005 |
| 2 | Topoisomerase Inhibitor [EPC] | 21 | 0.0003 |
| 3 | Bile Acid Sequestrant [EPC] | 3 | 0.0002 |
| 4 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Sulfone [EPC] | 2 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |